An alkaloid initiates phosphodiesterase 3A-schlafen 12 dependent apoptosis without affecting the phosphodiesterase
Youwei Ai1,2,3, Haibing He4, Peihao Chen5,6
1College of Wildlife and Protected Area, Northeast Forestry University, Hexing Road, 150040, Harbin, China. aiyouwei@nibs.ac.cn.
Abstract:
The promotion of apoptosis in tumor cells is a popular strategy for developing anti-cancer drugs. Here, we demonstrate that the plant indole alkaloid natural product nauclefine induces apoptosis of diverse cancer cells via a PDE3A-SLFN12 dependent death pathway. Nauclefine binds PDE3A but does not inhibit the PDE3A's phosphodiesterase activity, thus representing a previously unknown type of PDE3A modulator that can initiate apoptosis without affecting PDE3A's canonical function. We demonstrate that PDE3A's H840, Q975, Q1001, and F1004 residues-as well as I105 in SLFN12-are essential for nauclefine-induced PDE3A-SLFN12 interaction and cell death. Extending these molecular insights, we show in vivo that nauclefine inhibits tumor xenograft growth, doing so in a PDE3A- and SLFN12-dependent manner. Thus, beyond demonstrating potent cytotoxic effects of an alkaloid natural product, our study illustrates a potentially side-effect-reducing strategy for targeting PDE3A for anti-cancer therapeutics without affecting its phosphodiesterase activity.
Insights
Nauclefine, a plant alkaloid, triggers cancer cell death through a novel pathway involving PDE3A and SLFN12. This discovery offers a potential anti-cancer strategy with reduced side effects by targeting PDE3A without inhibiting its normal function.
Area of Science:
- Molecular Biology
- Pharmacology
- Cancer Research
Background:
- Inducing apoptosis in tumor cells is a key strategy for anti-cancer drug development.
- Targeting specific molecular pathways offers potential for more effective and less toxic cancer therapies.
Purpose of the Study:
- To investigate the mechanism of action of the plant alkaloid nauclefine in inducing cancer cell apoptosis.
- To identify the molecular targets and pathways involved in nauclefine-mediated cell death.
- To explore the therapeutic potential of nauclefine as an anti-cancer agent.
Main Methods:
- Investigated nauclefine's interaction with phosphodiesterase 3A (PDE3A) and its binding partner SLFN12.
- Utilized molecular biology techniques to identify key residues in PDE3A and SLFN12 essential for nauclefine's action.
- Assessed nauclefine's efficacy in inhibiting tumor xenograft growth in vivo.
Main Results:
- Nauclefine induces apoptosis in diverse cancer cells via a novel PDE3A-SLFN12 dependent pathway.
- Nauclefine binds PDE3A without inhibiting its phosphodiesterase activity, representing a new class of modulator.
- Specific residues in PDE3A and SLFN12 are critical for nauclefine-induced cell death and tumor growth inhibition.
Conclusions:
- Nauclefine is a potent inducer of cancer cell apoptosis through a unique mechanism involving PDE3A and SLFN12.
- This study presents a novel strategy for anti-cancer therapeutics by modulating PDE3A activity without affecting its canonical function, potentially reducing side effects.
- Nauclefine demonstrates in vivo efficacy in inhibiting tumor growth, supporting its potential as a therapeutic agent.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
12:55Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Related Concept Videos
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
01:24Caspases
01:22Amplifying Signals via Enzymatic Cascade
01:31The Intrinsic Apoptotic Pathway
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...